ADRB3 and metabolic dysfunction-associated steatotic liver disease: In overweight/obese subjects (n = 285), the effect of the ADRB3 C/C genotype is modeled directly on the latent variable affecting an increased BMI and HOMA-IR and indirectly on the risk of developing NAFLD (Figure 3).